Doward LC, McKenna SP, Meads DM, Kavyasiddhi D, Hampson NE, Mayo KW. The symptomatic, functional and quality of life impact of multiple sclerosis: report on a qualitative investigation of the patients' perspective. Poster presented at the 2005 ISPOR 8th Annual European Congress; November 2005. Florence, Italy. [abstract] Value Health. 2005 Nov; 8(6):A135.
Hampson NE, Meads DM, McKenna SP, Doward LC, Turk F. Factors influencing quality of life in atopic dermatitis. Poster presented at the 2005 ISPOR 8th Annual European Congress; November 2005. Florence, Italy. [abstract] Value Health. 2005 Nov; 8(6):A149.
Zhou X, Radigue C, Maneval F, Coste F. Validity of data collected from an internet-based cohort study. Poster presented at the 2005 ISPOR 8th Annual European Congress; November 8, 2005. Florence. [abstract] Value Health. 2005 Nov; 8(6):A76.
Wolowacz SE, Roskell NS, Christie A, Kerr G, Cameron D. Per-patient cost of hospital care for advanced breast cancer in the UK based on a large patient-level resource utilisation dataset. Poster presented at the 2005 ISPOR 8th Annual European Congress; November 2005. Florence, Italy. [abstract] Value Health. 2005 Nov; 8(6):A42.
Earnshaw SR, Javitt JC, Graham CN, Brogan AJ, Zlateva GP, Shah S, Adamis AP. Modeling treatments for subfoveal choroidal neovascularization secondary to age-related macular degeneration: cost-effectiveness methods. Poster presented at the 2005 ISPOR 8th Annual European Congress; November 10, 2005. Florence, Italy. [abstract] Value Health. 2005 Nov; 8(6):A179.
Earnshaw SR, Javitt JC, Zlateva GP, Pleil AM, Graham CN, Brogan AJ, Shah S, Adamis AP. Cost-effectiveness model for age-related macular degeneration: comparing early and late Macugen® treatment. Poster presented at the 2005 ISPOR 8th Annual European Congress; November 10, 2005. Florence, Italy. [abstract] Value Health. 2005 Nov; 8(6).
Abetz L, Coombs JH, Keininger DL, Earle CC, Wade C, Bury-Maynard D, Copley-Merriman K, Hsu MA. Development of the cancer chemotherapy satisfaction questionnaire (CCSQ): item generation and content validity testing. Value Health. 2005 Nov;8(Suppl 1):S41-53.
McKenna SP, Meads DM, Doward LC, Tennant A. Improving the scaling properties of the Psychological General Well-Being Scale (PGWB). Poster presented at the 2005 ISPOR 10th Annual International Meeting; May 2005. Washington, DC. [abstract] Value Health. 2005 May; 8(3):380.
McKenna SP, Meads DM, Doward LC, Tennant A. Linking disease-specific quality of life (QoL) scales. Poster presented at the 2005 ISPOR 10th Annual International Meeting; May 2005. Washington, DC. [abstract] Value Health. 2005 May; 8(3):379.
Doward LC, Tai SJ, Taylor JL. An exploratory study to develop a model of quality of life for bipolar disorder. Poster presented at the 2005 ISPOR 10th Annual International Meeting; May 2005. Washington, DC. [abstract] Value Health. 2005 May; 8(3):390.
Davis KL, Candrilli SD, Kan H, Lucero MA, Covington M. Estimating the effects of diabetic peripheral neuropathy and diabetic retinopathy on quality-of-life using data from the 2001-2002 national health and nutrition examination survey. Poster presented at the 2005 ISPOR 10th Annual International Meeting; May 18, 2005. [abstract] Value Health. 2005 May; 8(3):365.
Davis KL, Candrilli SD, Kan HJ, Lucero MA, Covington MT. Estimating the effect of symptoms of diabetic peripheral neuropathy and diabetic retinopathy on quality-of-life using data from the 2001-2002 national health and nutrition examination survey. Poster presented at the 2005 ISPOR 10th Annual International Meeting; May 2005. Washington, DC. [abstract] Value Health. 2005 May; 8(3):365.
Candrilli SD, Davis KL, Kan H, Lucero MA, Covington M. Burden of illness associated with symptoms of diabetic peripheral neuropathy and diabetic retinopathy. Poster presented at the 2005 ISPOR 10th Annual International Meeting; May 18, 2005. [abstract] Value Health. 2005 May; 8(3):357.
Tafesse E, Claxton A, Granger AL, Sanders J, Apelian D, Atillasoy E, Iloeje U. Estimates of health care costs for lamivudine-refractory chronic hepatitis b (CHB) patients. Poster presented at the 2005 ISPOR 10th Annual International Meeting; May 18, 2005. [abstract] Value Health. 2005 May; 8(3):310.
Meads DM, McKenna SP, Doward LC, Hampson N. Interpreting scores on the Quality of Life Index for Atopic Dermatitis (QoLIAD). Poster presented at the 2005 ISPOR 10th Annual International Meeting; May 2005. Washington, DC. [abstract] Value Health. 2005 May; 8(3):331-2.
Yost KJ, Sorenson MV, Hahn EA, Glendenning GA, Gnanasakthy A, Cella D. Using multiple anchor- and distribution-based estimates to evaluate clinically meaningful change on the Functional Assessment of Cancer Therapy-Biologic Response Modifiers (FACT-BRM) instrument. Value Health. 2005 Mar;8(2):117-27.